Breaking News

Evotec SE Sells Chemical API Manufacturing Site

All business operations and workforce at Evotec DS in Halle/Westphalia will transition to Monacum Partners and continue business as DAPIN GmbH.

Author Image

By: Charlie Sternberg

Associate Editor

Evotec SE has announced the sale of its chemical API manufacturing site, Evotec DS GmbH, located in Halle/Westphalia, to Monacum Partners GmbH, a Munich-based Private Equity firm.   This transaction forms part of Evotec’s “Priority Reset” initiative launched in April 2024, which aims to foster profitable growth by refining the company’s operational footprint and focusing on its primary growth sectors and core competencies.   Evotec DS in Halle/Westphalia is a specialized CDMO (Contract Devel...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters